Morgan Stanley Maintains Overweight on Nutrien, Lowers Price Target to $81

Benzinga Newsdesk www.benzinga.com Negative 75.5%

Neg 75.5% Neu 0% Pos 0%

Morgan Stanley analyst Vincent Sinisi maintains Nutrien (NYSE:NTR) with a Overweight and lowers the price target from $93 to $81.